Document is current
Any future updates will be listed below
-
Authors
Ricketson, Leah J.
Doucette, Emily J.
Alatorre, Isabella
Tarannum, Tarannum
Gray, Joslyn
Booth, William
Tipples, Graham
Charlton, Carmen
Kanji, Jamil N.
Fonseca, Kevin
Kellner, James D.
-
Funding
Funding for this research was provided by:
Government of Alberta
Alberta Children’s Hospital Research Institute
- License Information
-
More Information
Article History
Received: 3 April 2024
Accepted: 15 July 2024
First Online: 18 July 2024
Declarations
:
: The study was carried out in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki and received approval from the University of Calgary Conjoint Health Research Ethics Board (REB20-0480). In accordance with the Tri-Council Policy Statement2 (TCPS2 2014), informed consent was obtained from the parents or legal guardians of all participating children, or directly from mature minors with decision-making capacity, prior to participation in the study.
: Not applicable.
: JDK has been an investigator on projects funded by GlaxoSmithKline, Merck, Moderna, and Pfizer, outside the submitted work. All funds have been paid to his institution, and he has not received any personal payments. He has been an unpaid member of the Canadian COVID-19 Immunity Task Force (Leadership Group member, Field Studies Working Party Co-Chair and Pediatric Network Lead), and of the Alberta Advisory Committee on Immunizations. All other authors have no conflicts of interest to declare.
